Bio-Rad Laboratories (BIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Sales | 1,784,244 | 1,764,365 | 1,461,052 | 1,273,930 | 1,180,985 |
| Cost of Goods | 784,401 | 801,843 | 669,690 | 561,394 | 534,499 |
| Gross Profit | 999,843 | 962,522 | 791,362 | 712,536 | 646,486 |
| Operating Expenses | 769,256 | 780,422 | 656,859 | 566,819 | 531,687 |
| Operating Income | 230,988 | 182,943 | 135,193 | 146,111 | 115,298 |
| Interest Expense | 47,024 | 32,113 | 31,606 | 32,022 | 32,643 |
| Other Income | 1,868 | -7,987 | 17,256 | 27,938 | 10,716 |
| Pre-tax Income | 185,832 | 142,843 | 120,843 | 142,027 | 93,371 |
| Income Tax | 36,667 | 44,579 | 26,548 | 38,764 | 15,792 |
| Net Income Continuous | 149,165 | 98,264 | 94,295 | 103,263 | 77,579 |
| Net Income Discontinuous | N/A | N/A | N/A | N/A | 3,974 |
| Minority Interests | 4,545 | 8,754 | 1,301 | N/A | N/A |
| Net Income | $144,620 | $89,510 | $92,994 | $103,263 | $81,553 |
| EPS Basic Total Ops | 5.28 | 3.30 | 3.48 | 3.92 | 3.13 |
| EPS Basic Continuous Ops | 5.44 | 3.62 | 3.53 | 3.92 | 2.98 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | N/A | 0.15 |
| EPS Diluted Total Ops | 5.20 | 3.24 | 3.41 | 3.83 | 3.06 |
| EPS Diluted Continuous Ops | 5.36 | 3.56 | 3.46 | 3.83 | 2.91 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | N/A | 0.15 |
| EBITDA(a) | $230,988 | $182,943 | $135,193 | $146,111 | $115,298 |